Lactate predicts 90-day acute-on-chronic liver failure in acute decompensated cirrhosis: A retrospective cohort study

Abstract Background & Aims Existing prognostic models demonstrate insufficient sensitivity in predicting acute-on-chronic liver failure (ACLF) among patients with cirrhosis experiencing acute decompensation (AD). We postulated that serum lactate levels, indicative of systemic metabolic dysregulation, could enhance the stratification of ACLF risk. Methods This retrospective cohort study included 831 hospitalized patients with AD from The Second Hospital of Nanjing, spanning the years 2015 to 2024. Serum lactate levels were assessed upon admission. The primary outcome was the development of ACLF, as defined by the EASL-CLIF criteria, within a 90-day period. Multivariable Cox regression, receiver operating characteristic (ROC) analysis, and competing risk models were employed to evaluate the prognostic significance of lactate levels and to establish an optimal threshold. A nomogram was subsequently developed and subjected to internal validation. Results ACLF developed in 272/831 (32.7%) patients. ACLF patients had higher lactate (median 4.6 vs 3.5 mmol/L, p<0.001). Each 1-mmol/L lactate increase independently predicted ACLF risk (HR 1.16, 95% CI 1.10–1.22). A lactate threshold of 4.8 mmol/L stratified high-risk patients (sensitivity 47.8%, specificity 72.8%). A nomogram integrating lactate, infection, INR, bilirubin, and creatinine outperformed traditional models (AUC 0.783 vs MELD 0.701). Results remained robust in competing risk analyses (sHR 1.15, 95% CI 1.07–1.23). Conclusions Lactate is an independent predictor of 90-day ACLF in AD cirrhosis. A cut-off of 4.8 mmol/L enhances risk stratification, and lactate-integrated models improve prognostic accuracy. Routine lactate measurement may guide early intervention.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-13
DOI
https://doi.org/10.21203/rs.3.rs-11313343/v1
Primary Topic
Liver Disease and Transplantation
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Lactate predicts 90-day acute-on-chronic liver failure in acute decompensated cirrhosis: A retrospective cohort study

杨永峰, Ruiqi Li, Changhua Yi, Jun Guo et al.
2 links
Research Square
Liver Disease and Transplantation
preprint

Lactate predicts 90-day acute-on-chronic liver failure in acute decompensated cirrhosis: A retrospective cohort study

杨永峰, Ruiqi Li, Changhua Yi, Jun Guo, Xixuan Wang, Shuling Chen, Qingfang Xiong, Xiaoying Dong, Jiale Shen, Caiyun Zhang, Hongli Liu, Hao Ren
preprint en

Abstract

Abstract Background & Aims Existing prognostic models demonstrate insufficient sensitivity in predicting acute-on-chronic liver failure (ACLF) among patients with cirrhosis experiencing acute decompensation (AD). We postulated that serum lactate levels, indicative of systemic metabolic dysregulation, could enhance the stratification of ACLF risk. Methods This retrospective cohort study included 831 hospitalized patients with AD from The Second Hospital of Nanjing, spanning the years 2015 to 2024. Serum lactate levels were assessed upon admission. The primary outcome was the development of ACLF, as defined by the EASL-CLIF criteria, within a 90-day period. Multivariable Cox regression, receiver operating characteristic (ROC) analysis, and competing risk models were employed to evaluate the prognostic significance of lactate levels and to establish an optimal threshold. A nomogram was subsequently developed and subjected to internal validation. Results ACLF developed in 272/831 (32.7%) patients. ACLF patients had higher lactate (median 4.6 vs 3.5 mmol/L, p<0.001). Each 1-mmol/L lactate increase independently predicted ACLF risk (HR 1.16, 95% CI 1.10–1.22). A lactate threshold of 4.8 mmol/L stratified high-risk patients (sensitivity 47.8%, specificity 72.8%). A nomogram integrating lactate, infection, INR, bilirubin, and creatinine outperformed traditional models (AUC 0.783 vs MELD 0.701). Results remained robust in competing risk analyses (sHR 1.15, 95% CI 1.07–1.23). Conclusions Lactate is an independent predictor of 90-day ACLF in AD cirrhosis. A cut-off of 4.8 mmol/L enhances risk stratification, and lactate-integrated models improve prognostic accuracy. Routine lactate measurement may guide early intervention.

Research Square
Nanjing University of Chinese Medicine (CN), Southeast University (CN)
Government of Jiangsu Province, Natural Science Foundation of Jiangsu Province
Good health and well-being
Liver Disease and Transplantation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon